期刊
IMMUNOBIOLOGY
卷 221, 期 10, 页码 1080-1090出版社
ELSEVIER GMBH
DOI: 10.1016/j.imbio.2016.06.007
关键词
Transgenic mouse; C3G; aHUS; PNH; Complement
类别
Remarkable advances have been made over past decades in understanding the pathogenesis of complement-mediated diseases. This. has led to development of new therapies for, and in some cases re-classification of, complement-driven diseases. This success is due to not only insight from human patients but also studies using transgenic animal models. Animal models that mimic human diseases are useful tools to understand the mechanism of disease and develop new therapies but there are also limitations due to species differences in their complement systems. This review provides a summary of transgenic animal models for three human diseases that are at the forefront of anti-complement therapy, paroxysmal nocturnal hemoglobinuria (PNH), atypical hemolytic uremic syndrome (aHUS) and C3 glomerulopathy (C3G). They are discussed here as examples to highlight the values and limitations of animal modeling in complement-driven diseases. (C) 2016 Published by Elsevier GmbH.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据